Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Sajjad MU, Henriksen T, Haugen G, Michelsen TM(2025) Placental hexokinase activity is related to fetal blood flow distribution in a cross-sectional study of healthy human pregnancies at term Placenta, 168, 1-8(in press) DOI 10.1016/j.placenta.2025.05.015, PubMed 40446728
van der Meer D, Rahman Z, Ottas A, Parekh P, Kutrolli G, Stinson SE, Koromina M, Rokicki J, Sønderby IE, Parker N, Tesfaye M, Hindley G, Rødevand LN, Koch E, Estonian Biobank Research Team, Steen NE, Berg JP, O'Connell KS, Smeland OB, Frei O, Dale AM, Djurovic S, Lehto K, Alver M, Milani Let al.(2025) Pleiotropic and sex-specific genetic mechanisms of circulating metabolic markers Nat Commun, 16(1), 4961 DOI 10.1038/s41467-025-60058-z, PubMed 40436851
Vikedal K, Ræder SB, Riisnæs IMM, Bjørås M, Booth JA, Skarstad K, Helgesen E(2025) RecN and RecA orchestrate an ordered DNA supercompaction response following ciprofloxacin-induced DNA damage in Escherichia coli Nucleic Acids Res, 53(10) DOI 10.1093/nar/gkaf437, PubMed 40433982